Tom or Tommy Adams may refer toNasal EPAP Expiratory Positive Airway Pressure is a treatment for snoring and obstructive sleep apnea OSA. Nasal EPAP utilizes the users own breathing to create 14816826 positive airway pressure to prevent obstructed breathing. The first commercially available nasal EPAP device indicated for the treatment of obstructive sleep apnea Provent Therapy was cleared by the United States FDA in 2008. To treat snoring, overthecounter devices like Theravent are now available using the same nasal EPAP technology. In a series of published articles, nasal EPAP has been shown to provide statistically significant reductions 14816826 in apnea hypopnea index AHI, oxygen desaturation index ODI and sleepiness, with high patient acceptance and compliance. It has also been proven, through clinical tests, to reduce snoring by 76.fa136e57392093479095a5a40f033715.